Clinigen Group (CLIN)

 

Latest News

Form 8.3 - Clinigen Group

RNS Number: 7051O GVQ Investment Management Ltd 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: GVQ Investm...

Form 8.3 - Clinigen Group Plc

Form 8.3 - Clinigen Group Plc OBERWEIS ASSET FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Oberweis Asset Management, Inc...

Form 8.3 - Clinigen Group plc

RNS Number: 6917O BlackRock Group 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: BlackRock, Inc. (b) Owner or ...

Form 8.3 - Quantum Pharma plc

RNS Number: 6893O FIL Limited 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: FMR LLC and/or one or more of it...

All News

DateHeadlineSource
22-08-17Form 8.3 - Clinigen GroupRNS
22-08-17Form 8.3 - Clinigen Group PlcRNS
22-08-17Form 8.3 - Clinigen Group plcRNS
22-08-17Form 8.3 - Quantum Pharma plcRNS
22-08-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
21-08-17Form 8.3 - Clinigen Group plcRNS
21-08-17Form 8.3 - Clinigen Group plcRNS
21-08-17Form 8.3 - Clinigen Group plcRNS
21-08-17Form 8.3 - Clinigen Group PlcRNS
21-08-17Form 8.3 - Quantum Pharma plcRNS
21-08-17Form 8.3 - Clinigen Group PlcRNS
21-08-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
18-08-17Form 8.3 - Clinigen Group plcRNS
18-08-17Form 8.3 - Clinigen Group plcRNS
18-08-17Form 8.3 - Quantum Pharma PlcRNS
18-08-17Form 8.3 - Clinigen Group plcRNS
18-08-17Form 8.3 - Clinigen Group PlcRNS
18-08-17Form 8.3 - Clinigen Group PlcRNS
18-08-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group plcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group plcRNS
17-08-17Form 8.3 - [Clinigen Group plc]RNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Quantum Pharma PlcRNS
17-08-17Form 8 (OPD) - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.5 (EPT/RI) - clinigenRNS
17-08-17Form 8.3 - Clinigen Group plcRNS
17-08-17Form 8.3 - Clinigen Group PlcRNS
17-08-17Form 8.3 - Clinigen Group plcRNS
17-08-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
17-08-17Clinigen confirms possible offer for Quantum Pharma StockMarketWire
17-08-17Possible Offer for Quantum Pharma plcRNS
16-08-17Form 8.3 - Clinigen Group Plc AmendmentRNS
16-08-17Form 8.3 - Clinigen Group PlcRNS
16-08-17Statement re Possible OfferRNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory